These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 18945509)

  • 81. [Diabetes mellitus and its complications in Japan. Late complications of diabetes mellitus--estimation of risk factors in patients on sulfonylureas (Su) more than 10 years].
    Hoshi M; Fujita S
    Nihon Naika Gakkai Zasshi; 1991 Sep; 80(9):1432-3. PubMed ID: 1761923
    [No Abstract]   [Full Text] [Related]  

  • 82. Prolonged hypoglycaemia secondary to extended-release form glipizide.
    Cakir M; Akin M; Karayalcin U
    Diabetes Obes Metab; 2004 Jul; 6(4):310-1. PubMed ID: 15171757
    [No Abstract]   [Full Text] [Related]  

  • 83. [Hyponatremia due to glipizide].
    Ducobu J; Dupont P
    Therapie; 1981; 36(5):597-8. PubMed ID: 7324000
    [No Abstract]   [Full Text] [Related]  

  • 84. ACP Journal Club: metformin reduced CV events compared with glipizide in patients with type 2 diabetes and CAD.
    Tanner M
    Ann Intern Med; 2013 Apr; 158(8):JC4. PubMed ID: 23588769
    [No Abstract]   [Full Text] [Related]  

  • 85. Glibenclamide induced photosensitivity.
    Singal A; Bhattacharya SN; Baruah MC
    Indian J Dermatol Venereol Leprol; 2002; 68(4):240-1. PubMed ID: 17656954
    [TBL] [Abstract][Full Text] [Related]  

  • 86. What are the risk factors for progression of coronary artery calcification in patients with type 2 diabetes?
    Rydén L
    Nat Clin Pract Cardiovasc Med; 2008 Jul; 5(7):370-1. PubMed ID: 18477984
    [No Abstract]   [Full Text] [Related]  

  • 87. Hexaferrocenylbenzene.
    Yu Y; Bond AD; Leonard PW; Lorenz UJ; Timofeeva TV; Vollhardt KP; Whitener GD; Yakovenko AA
    Chem Commun (Camb); 2006 Jun; (24):2572-4. PubMed ID: 16779481
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Metformin in combination with various insulin secretagogues in type 2 diabetes and associated risk of cardiovascular morbidity and mortality--a retrospective nationwide study.
    Mogensen UM; Andersson C; Fosbøl EL; Schramm TK; Vaag A; Scheller NM; Torp-Pedersen C; Gislason G; Køber L
    Diabetes Res Clin Pract; 2015 Jan; 107(1):104-12. PubMed ID: 25458330
    [TBL] [Abstract][Full Text] [Related]  

  • 89. The risk of overall mortality in patients with type 2 diabetes receiving glipizide, glyburide, or glimepiride monotherapy: a retrospective analysis.
    Pantalone KM; Kattan MW; Yu C; Wells BJ; Arrigain S; Jain A; Atreja A; Zimmerman RS
    Diabetes Care; 2010 Jun; 33(6):1224-9. PubMed ID: 20215447
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Ethiopian patients' perceptions of anti-diabetic medications: implications for diabetes education.
    Habte BM; Kebede T; Fenta TG; Boon H
    J Pharm Policy Pract; 2017; 10():14. PubMed ID: 28405339
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Place of sulfonylureas in the management of type 2 diabetes mellitus in South Asia: A consensus statement.
    Kalra S; Aamir AH; Raza A; Das AK; Azad Khan AK; Shrestha D; Qureshi MF; Md Fariduddin ; Pathan MF; Jawad F; Bhattarai J; Tandon N; Somasundaram N; Katulanda P; Sahay R; Dhungel S; Bajaj S; Chowdhury S; Ghosh S; Madhu SV; Ahmed T; Bulughapitiya U
    Indian J Endocrinol Metab; 2015; 19(5):577-96. PubMed ID: 26425465
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Observational studies of the association between glucose-lowering medications and cardiovascular outcomes: addressing methodological limitations.
    Patorno E; Patrick AR; Garry EM; Schneeweiss S; Gillet VG; Bartels DB; Masso-Gonzalez E; Seeger JD
    Diabetologia; 2014 Nov; 57(11):2237-50. PubMed ID: 25212258
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Safety and efficacy of gliclazide as treatment for type 2 diabetes: a systematic review and meta-analysis of randomized trials.
    Landman GW; de Bock GH; van Hateren KJ; van Dijk PR; Groenier KH; Gans RO; Houweling ST; Bilo HJ; Kleefstra N
    PLoS One; 2014; 9(2):e82880. PubMed ID: 24533045
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Cardiovascular effects of anti-diabetic medications in type 2 diabetes mellitus.
    Singh S; Bhat J; Wang PH
    Curr Cardiol Rep; 2013 Jan; 15(1):327. PubMed ID: 23250663
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Metformin, but not glimepiride, improves carotid artery diameter and blood flow in patients with type 2 diabetes mellitus.
    Machado HA; Vieira M; Cunha MR; Correia MR; Fukui RT; Santos RF; Rocha DM; Wajchenberg BL; Lage SG; Silva ME
    Clinics (Sao Paulo); 2012 Jul; 67(7):711-7. PubMed ID: 22892913
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Effect of plasminogen activator inhibitor-1 and tissue plasminogen activator polymorphisms on susceptibility to type 2 diabetes in Malaysian subjects.
    Al-Hamodi Z; Saif-Ali R; Ismail IS; Ahmed KA; Muniandy S
    J Biomed Biotechnol; 2012; 2012():234937. PubMed ID: 22577291
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Risk of coronary artery disease associated with initial sulphonylurea treatment of patients with type 2 diabetes: a matched case-control study.
    Sadikot SM; Mogensen CE
    Diabetes Res Clin Pract; 2008 Dec; 82(3):391-5. PubMed ID: 18945509
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Sulphonylureas and cancer: a case-control study.
    Monami M; Lamanna C; Balzi D; Marchionni N; Mannucci E
    Acta Diabetol; 2009 Dec; 46(4):279-84. PubMed ID: 19082520
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Increase in overall mortality risk in patients with type 2 diabetes receiving glipizide, glyburide or glimepiride monotherapy versus metformin: a retrospective analysis.
    Pantalone KM; Kattan MW; Yu C; Wells BJ; Arrigain S; Jain A; Atreja A; Zimmerman RS
    Diabetes Obes Metab; 2012 Sep; 14(9):803-9. PubMed ID: 22486923
    [TBL] [Abstract][Full Text] [Related]  

  • 100.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.